NM_001322934.2:c.1962C>T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001322934.2(NFKB2):​c.1962C>T​(p.Val654Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,592,402 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 11 hom. )

Consequence

NFKB2
NM_001322934.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.332

Publications

2 publications found
Variant links:
Genes affected
NFKB2 (HGNC:7795): (nuclear factor kappa B subunit 2) This gene encodes a subunit of the transcription factor complex nuclear factor-kappa-B (NFkB). The NFkB complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The protein encoded by this gene can function as both a transcriptional activator or repressor depending on its dimerization partner. The p100 full-length protein is co-translationally processed into a p52 active form. Chromosomal rearrangements and translocations of this locus have been observed in B cell lymphomas, some of which may result in the formation of fusion proteins. There is a pseudogene for this gene on chromosome 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
NFKB2 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 10
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • deficiency in anterior pituitary function - variable immunodeficiency syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 10-102400818-C-T is Benign according to our data. Variant chr10-102400818-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00216 (328/151722) while in subpopulation NFE AF = 0.00289 (196/67922). AF 95% confidence interval is 0.00255. There are 1 homozygotes in GnomAd4. There are 146 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 328 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB2NM_001322934.2 linkc.1962C>T p.Val654Val synonymous_variant Exon 17 of 23 ENST00000661543.1 NP_001309863.1 Q00653-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB2ENST00000661543.1 linkc.1962C>T p.Val654Val synonymous_variant Exon 17 of 23 NM_001322934.2 ENSP00000499294.1 Q00653-1

Frequencies

GnomAD3 genomes
AF:
0.00216
AC:
328
AN:
151604
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000510
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00197
Gnomad ASJ
AF:
0.0207
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000949
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00289
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.00260
AC:
570
AN:
219630
AF XY:
0.00247
show subpopulations
Gnomad AFR exome
AF:
0.000437
Gnomad AMR exome
AF:
0.00150
Gnomad ASJ exome
AF:
0.0202
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000320
Gnomad NFE exome
AF:
0.00314
Gnomad OTH exome
AF:
0.00478
GnomAD4 exome
AF:
0.00308
AC:
4444
AN:
1440680
Hom.:
11
Cov.:
39
AF XY:
0.00309
AC XY:
2205
AN XY:
714104
show subpopulations
African (AFR)
AF:
0.000450
AC:
15
AN:
33308
American (AMR)
AF:
0.00161
AC:
67
AN:
41608
Ashkenazi Jewish (ASJ)
AF:
0.0200
AC:
501
AN:
25058
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39232
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83554
European-Finnish (FIN)
AF:
0.000459
AC:
24
AN:
52336
Middle Eastern (MID)
AF:
0.000704
AC:
4
AN:
5678
European-Non Finnish (NFE)
AF:
0.00329
AC:
3623
AN:
1100296
Other (OTH)
AF:
0.00352
AC:
210
AN:
59610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
246
491
737
982
1228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00216
AC:
328
AN:
151722
Hom.:
1
Cov.:
32
AF XY:
0.00197
AC XY:
146
AN XY:
74114
show subpopulations
African (AFR)
AF:
0.000508
AC:
21
AN:
41304
American (AMR)
AF:
0.00197
AC:
30
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0207
AC:
72
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4774
European-Finnish (FIN)
AF:
0.0000949
AC:
1
AN:
10542
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00289
AC:
196
AN:
67922
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00386
Hom.:
2
Bravo
AF:
0.00223

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency, common variable, 10 Benign:2
Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NFKB2-related disorder Benign:1
Aug 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NFKB2: BP4, BP7 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
12
DANN
Benign
0.86
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201623844; hg19: chr10-104160575; API